Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms

被引：0
|
作者：
Tashi, Tsewang [1 ]
Deininger, Michael W. [2 ]
机构：
[1] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, 2000 Circle Hope, Salt Lake City, UT 84112 USA
[2] Med Coll Wisconsin, Versiti Blood Res Inst, Div Hematol & Oncol, 8727 West Water town Plank Rd, Milwaukee, WI 53226 USA
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2023年 / 43卷 / 04期
关键词：
Systemic mastocytosis; Associated hematologic neoplasm; KIT D816 V; KIT inhibitors; Tryptase; Avapritinib; MAST-CELL DISORDERS; C-KIT MUTATION; IMATINIB MESYLATE; TREATMENT OPTIONS; TYROSINE KINASE; RESPONSE CRITERIA; INTERFERON-ALPHA; TRYPTASE LEVELS; LEUKEMIA; EFFICACY;
D O I：
10.1016/j.iac.2023.04.009
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：723 / 741
页数：19
相关论文
共 50 条
  • [31] Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases
    Mimiola, Elda
    Bomben, Riccardo
    De Matteis, Giovanna
    Perbellini, Omar
    Guglielmelli, Paola
    Bonifacio, Massimiliano
    Parisi, Alice
    Gattei, Valter
    Zamo, Alberto
    Mannelli, Francesco
    Garcia Montero, Andrs Celesteino
    Zanotti, Roberta
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 628 - 633
  • [32] Treatment of Advanced Systemic Mastocytosis with Midostaurin: Practical Guidance for Optimal Therapy and Management
    Papayannidis, Cristina
    Federico, Vincenzo
    Fianchi, Luana
    Pregno, Patrizia
    Pugliese, Novella
    Romano, Alessandra
    Grifoni, Federica Irene
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2022, 14
  • [33] Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurin
    Gotlib, Jason
    Kluin-Nelemans, Hanneke C.
    Akin, Cem
    Hartmann, Karin
    Valent, Peter
    Reiter, Andreas
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 487 - 498
  • [34] PSYCHOMETRIC EVALUATION OF THE ADVANCED SYSTEMIC MASTOCYTOSIS SYMPTOM ASSESSMENT FORM (ADVSM-SAF) IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS
    Taylor, F.
    Shields, A.
    Li, S.
    Yip, C.
    Padilla, B.
    Green, T.
    Radia, D.
    Deininger, M.
    Gotlib, J. R.
    Bose, P.
    Drummond, M. W.
    Hexner, E.
    Robinson, W.
    Quiery, A. J., Jr.
    Winton, E. F.
    DeAngelo, D. J.
    Mar, B.
    VALUE IN HEALTH, 2019, 22 : S868 - S868
  • [35] Tyrosine Kinase Inhibitors in the Treatment of Eosinophilic Neoplasms and Systemic Mastocytosis
    Gotlib, Jason
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (04) : 643 - +
  • [36] SYSTEMIC MASTOCYTOSIS WITH MYELOID SPLENOMEGALY TYPE HEMATOLOGICAL MANIFESTATIONS
    KRULIK, M
    BRIVET, F
    AUDEBERT, AA
    CURIONI, S
    DEBRAY, J
    ANNALES DE MEDECINE INTERNE, 1977, 128 (03): : 245 - 253
  • [37] CONCURRENT ACUTE MYELOID-LEUKEMIA AND SYSTEMIC MASTOCYTOSIS
    WONG, KF
    CHAN, JKC
    CHAN, JCW
    KWONG, YL
    MA, SK
    CHOW, TC
    AMERICAN JOURNAL OF HEMATOLOGY, 1991, 38 (03) : 243 - 244
  • [38] Towards molecular management of systemic mastocytosis
    Silvain, C
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2004, 28 (01): : 33 - 34
  • [39] CROMOLYN SODIUM IN THE MANAGEMENT OF SYSTEMIC MASTOCYTOSIS
    HORAN, RF
    SHEFFER, AL
    AUSTEN, KF
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 85 (05) : 852 - 855
  • [40] Systemic mastocytosis associated with a blood mastocytosis and a gastric ulcer in a cat
    Mai, W
    Bouhoula, L
    POINT VETERINAIRE, 1998, 29 (195): : 65 - 69
12345